Histone Therapeutics
UEI: Z5GXNK5L2R11
• CAGE: 96Q26
Overview
Awardee Type
Parent
Name
Histone Therapeutics
Headquarters
Seattle, WA
United States
United States
Most Recent Award
Aug. 1, 2023
Calculating
Federal grant recipient
HISTONE THERAPEUTICS CORP.
(UEI Z5GXNK5L2R11, CAGE 96Q26)
is headquartered in Seattle WA.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in April 2021 and
federally registered in
October 2021.
Federal Award Analysis
Histone Therapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
HISTONE THERAPEUTICS CORP.
UEI
Z5GXNK5L2R11
CAGE Code
96Q26
SBA Certifications
None
Self Certifications
For Profit Organization, Subchapter S Corporation
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
April 26, 2021
Initial Registration
Oct. 14, 2021
Last Registration
Oct. 31, 2024
Registration Activation
Oct. 28, 2024
Registration Expiration
Oct. 18, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Subchapter S Corporation
Subchapter S Corporation
State of Incorporation
WA
Country of Incorporation
USA
Employees
<500
Accepts Credit Cards
No